Li Watsek
Stock Analyst at Cantor Fitzgerald
(0.21)
# 4,288
Out of 4,456 analysts
116
Total ratings
38.2%
Success rate
-9.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Li Watsek
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTH Faeth Therapeutics | Maintained: Buy | n/a | $22.87 | - | 2 | Jun 3, 2026 | |
| ZLAB Zai Lab | Maintained: Buy | $37 | $18.00 | +105.56% | 8 | Apr 29, 2026 | |
| REPL Replimune Group | Downgraded: Hold | n/a | $11.63 | - | 5 | Apr 10, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $300 | $260.75 | +15.05% | 24 | Apr 1, 2026 | |
| CRIS Curis | Rated: Hold | n/a | $0.321 | - | 4 | Mar 27, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | n/a | $31.88 | - | 2 | Mar 4, 2026 | |
| AVBP ArriVent BioPharma | Initiated Coverage: Buy | n/a | $34.00 | - | 1 | Dec 22, 2025 | |
| CMPX Compass Therapeutics | Initiated Coverage: Buy | n/a | $2.08 | - | 1 | Dec 3, 2025 | |
| RCUS Arcus Biosciences | Reiterated: Buy | n/a | $31.00 | - | 6 | Oct 8, 2025 | |
| CNTX Context Therapeutics | Initiated Coverage: Buy | n/a | $0.58 | - | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.00 | - | 6 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.74 | - | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.90 | n/a | 8 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.49 | n/a | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.68 | n/a | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $4.12 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.04 | n/a | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.10 | n/a | 5 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $0.2445 | n/a | 4 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.10 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $0.0127 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.54 → $54.10 | $2.25 | n/a | 3 | Jun 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $38 | $2.83 | n/a | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $6 | $12.39 | n/a | 3 | Jun 28, 2022 |
Faeth Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $22.87
Upside: -
Zai Lab
Apr 29, 2026
Maintained: Buy
Price Target: $37
Current: $18.00
Upside: +105.56%
Replimune Group
Apr 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $11.63
Upside: -
Ascendis Pharma
Apr 1, 2026
Maintained: Buy
Price Target: $300
Current: $260.75
Upside: +15.05%
Curis
Mar 27, 2026
Rated: Hold
Price Target: n/a
Current: $0.321
Upside: -
Tyra Biosciences
Mar 4, 2026
Maintained: Buy
Price Target: n/a
Current: $31.88
Upside: -
ArriVent BioPharma
Dec 22, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $34.00
Upside: -
Compass Therapeutics
Dec 3, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $2.08
Upside: -
Arcus Biosciences
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $31.00
Upside: -
Context Therapeutics
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $0.58
Upside: -
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $8.00
Upside: -
Sep 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $36.74
Upside: -
Jun 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $10.90
Upside: n/a
Jun 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $13.49
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.68
Upside: n/a
May 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $4.12
Upside: n/a
Jan 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.04
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: n/a
Current: $4.10
Upside: n/a
Aug 30, 2023
Maintained: Buy
Price Target: $11
Current: $0.2445
Upside: n/a
Aug 9, 2023
Reiterated: Hold
Price Target: $5
Current: $2.10
Upside: n/a
Aug 7, 2023
Reiterated: Buy
Price Target: $8 → $5
Current: $0.0127
Upside: n/a
Jun 11, 2023
Reiterated: Buy
Price Target: $8.54 → $54.10
Current: $2.25
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $71 → $38
Current: $2.83
Upside: n/a
Jun 28, 2022
Maintained: Buy
Price Target: $16 → $6
Current: $12.39
Upside: n/a